Investor
Every published round Global Health Investment Fund took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
Companies Global Health Investment Fund has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| No portfolio companies recorded yet. | ||||
Fund closes reported for Global Health Investment Fund, as distinct from the investments it has made.
Companies Global Health Investment Fund has backed that another company then bought. An exit for the holding, not a deal Global Health Investment Fund did.
Stories naming Global Health Investment Fund. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Atomo Diagnostics' oversubscribed $30 million IPO closed early ahead of its ASX listing, and the Sydney diagnostics firm signed a supply deal with NG Biotech for millions of COVID-19 rapid tests.
Also Startup Daily·Techboard
A blood-testing startup is adapting its self-testing technology for COVID-19 and pressing on with ASX listing preparations despite market turmoil, having earlier been backed by its founder and grant funding.